Current guidelines recommend inhalation therapy as the preferred route of drug
administration for treating patients with chronic obstructive pulmonary disease (COPD) …

Current guidelines recommend inhalation therapy as the preferred route of drug
administration for treating chronic obstructive pulmonary disease (COPD). Previous …

Current guidelines recommend inhaled pharmacologic therapy as the preferred route of
administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics) are the …

Chronic obstructive pulmonary disease (COPD) continues to be associated with increased
morbidity and mortality risk in spite of updated guidelines and a better understanding of this …

A variety of inhaler devices are available for delivering treatments to patients with chronic
obstructive pulmonary disease, and new inhalers are currently being developed. Each type …

Chronic obstructive pulmonary disease (COPD) is a progressive disease characterized by
airflow limitation resulting from emphysema and chronic bronchitis. Inhaled therapy is the …

For patients with COPD, inhalation is the preferred route of administration of respiratory
drugs for both maintenance and acute treatment. Numerous inhaler types and devices have …

Chronic obstructive pulmonary disease (COPD) is an increasingly important cause of
morbidity and mortality, pathological features of which are pulmonary inflammation and …

Sustained bronchodilation using inhaled medications in moderate to severe chronic
obstructive pulmonary disease (COPD) grades 2 and 3 (Global Initiative for Chronic …

Inhaled aerosol drugs commonly used by patients with chronic obstructive pulmonary
disease include short-acting and long-acting bronchodilators, as well as corticosteroids …